EXANE DERIVATIVES - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$26,525,000
-75.6%
40,660
-10.1%
0.01%
-72.0%
Q2 2021$108,542,000
-33.3%
45,2270.0%0.02%
-46.8%
Q1 2021$162,810,000
+475.7%
45,227
+303.0%
0.05%
+487.5%
Q4 2020$28,281,00011,2230.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders